Judith Dierlamm

Prof. Judith Dierlamm is a Professor and Senior Physician at the University Medical Center Hamburg-Eppendorf (UKE), affiliated with the Faculty of Medicine and II. Medical Clinic and Polyclinic. Her primary roles include clinical care in hematology and oncology, with a focus on malignant disorders like lymphoma and molecular oncology research. She leads the Center for Oncology and specializes in translational research, bridging clinical practice with advancements in immunotherapy and targeted treatments.

Research Interests:

• Molecular mechanisms in hematologic malignancies
• Immunotherapeutic strategies for lymphomas
• Clinical trials evaluating novel treatment protocols
• Genetic and epigenetic profiling of cancers
• Impact of socioeconomic factors on cancer outcomes

Articles Trends: Her recent work emphasizes PET-guided treatment protocols for Hodgkin lymphoma, immune checkpoint inhibitors in oncology, and molecular studies on somatic mutations in glioma. Collaborations span clinical trials and preclinical models, such as AAV-based gene therapy for kidney diseases.

Labs/Teams: Active in the UKE's Department of Internal Medicine, collaborating with the Oncology and Molecular Neurobiology research groups. Involved in the European Mantle Cell Lymphoma Network and German Hodgkin Study Group.